Multicenter studies of Lamivudine for the treatment and prevention of hepatitis B after liver transplantation.

Is hepatitis B immunoglobulin necessary in prophylaxis of hepatitis B recurrence after liver transplantation? A meta-analysis. PLoS One (2014) 0.81

A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med (1995) 4.84

Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med (1993) 4.43

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet (1997) 3.11

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology (1998) 2.01

Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol (1992) 1.46

Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431-435]. J Hepatol (2003) 1.44

Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology (1998) 1.05

Interferon alfa for recurrent hepatitis B infection after liver transplantation. Liver Transpl Surg (1996) 0.91

Medicare program; criteria for Medicare coverage of adult liver transplants--HCFA. Final notice. Fed Regist (1991) 0.85

Failure of interferon to prevent recurrent hepatitis B infection in hepatic allograft. Mayo Clin Proc (1989) 0.84